The Use Dexmedetomidine as a Total Intravenous Anesthesia–Propofol Adjuvant for Aneurysm Clipping
DOI:
https://doi.org/10.24244/jni.v15i1.732Keywords:
Aneurysm clipping, dexmedetomidine, intracranial aneurysmAbstract
Intracranial aneurysm is a cerebrovascular disease with a high mortality rate, particularly in cases of rupture. Aneurysm clipping surgery is one of the definitive management methods; however, it involves significant hemodynamic fluctuations that may lead to intraoperative complications and worsen prognosis. Hemodynamic stability and rapid anesthetic recovery are crucial aspects for the success of this procedure. We report a case of a 57-year-old female with a saccular aneurysm in the right M1 segment of the middle cerebral artery, scheduled for aneurysm clipping surgery. The patient had previously undergone decompressive craniectomy and hematoma evacuation due to non-traumatic intracranial hemorrhage, which was not initially diagnosed as an aneurysm, and showed no significant improvement postoperatively. In anesthetic management, dexmedetomidine was used as an adjuvant to maintain hemodynamic stability and support rapid recovery. Throughout the procedure with TIVA- Propofol, dexmedetomidine effectively maintained stable blood pressure without episodes of hypertension, hypotension, or bradycardia. The patient did not experience significant intraoperative complications, and postoperative recovery was optimal. This emphasizes the critical role of dexmedetomidine within modern anesthetic approaches to the management of intracranial aneurysm cases.
Downloads
References
Guo Z, Wang W, Xie D, Lin R. Effect of supplemental dexmedetomidine in interventional embolism on cerebral oxygen metabolism in patients with intracranial aneurysms. J Int Med Res. 2021;49(4):1–9. Doi: https://doi.org/10.1177/03000605211002960
Mastorakos P, Ding D, Peterson EC, Starke RM. General principles for the management of ruptured and unruptured intracranial aneurysms. In: Principles of neurological surger. Ellenbogen RG, Sekhar LN, Kitchen N, Eds. 4th ed. Philadelphia: Elsevier. 2018: 254–63. Doi: https://doi.org/10.1016/B978-0-323-43140-8.00016-0
Pong RP, Lam AM. Anesthetic management of cerebral aneurysm surgery. In: Cottrel JE, Patel PM, Soriano SG, eds. Cottrel and Patel’s neuroanesthesia. 7th ed. Philadelpia: Elsevier; 2023: 244–71. Doi: https://doi.org/10.1016/B978-0-323-93273-8.00013-4
Claybon MJ, Mashour GA. Dexmedetomidine and nitrous oxide for cerebral aneurysm clipping. In Case Studies in Neuroanesthesia and Neurociritical Care. Mashour GA, Farag E, eds.. New York: Cambridge University press; 2011: 63-65. Doi: https://doi.org/10.1017/CBO9780511997426.020.
Batra A, Verma R, , Bhatia VK, Chandra G, Bhushan S. Dexmedetomidine as an anesthetic adjuvant in intracranial surgery. Anesth Essays Res. 2017;11(2):309–13.Doi: https://doi.org/10.4103/0259- 1162.194555
Sharma D. Perioperative management of aneurysmal subarachnoid hemorrhage: a narrative review. Anesthesiology. 2020;133(6):1283–305. Doi: https://doi.org/10.1097/ALN.0000000000003558.
Onur OA, Fink GR, Kuramatsu JB, Schwab S. Aneurysmatic subarachnoid haemorrhage. Neurol Res Pract . 2019;1:15. Doi: https://doi.org/10.1186/s42466-019-0015-3.
Lantigua H, Ortega-Gutierrez S, Schmidt JM, Lee K, Badjatia N, Agarwal S, et al. Subarachnoid hemorrhage: who dies, and why. Crit Care. 2015;19(10):1-10. Doi: https://doi.org/10.1186/s13054- 015-1036-0.
Zheng D, Zhao S, Zhang N, Shi J. Brain protective effect and hemodynamics of dexmedetomidine hydrochloride in patients with intracranial aneurysm. Saudi J Biol Sci. 2020;27(7):1850–855. Doi: https://doi.org/10.1016/j.sjbs.2020.03.027.
Lecours M, Gelb AW. Anesthesia for the surgical treatment of cerebral aneurysms. Colombian J Anesthesiolog. 2015;43(s1):45–51. Doi: https://doi.org/10.1016/j.rcae.2014.09.003.
Li Q, He Y, Wu C, Liu S, Zhang S. Preliminary study on application of combined monitoring of neuroelectrophysiology-intracranial pressure-cerebral perfusion pressure in craniotomy for intracranial aneurysm clipping: an anatomical and clinical study. Int J Morphol. 2024;42(2):348–55.
Basali A, J Mascha E, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology. 2000;93(1):48–54. Doi: https://doi.org/10.1097/00000542-200007000-00012.
Peng K, Wu S, Liu H, Ji F. Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: Meta-analysis of randomized controlled trials. J Clin Neurosci. 2014;21(11):1951–8. Doi: https://doi.org/10.1016/j.jocn.2014.02.023.
Tasbihgou SR, Barends CRM, Absalom AR. The role of dexmedetomidine in neurosurgery. Best Pract Res Clin Anaesthesiol. 2020;35(2):221–29. Doi: https://doi.org/10.1016/j.bpa.2020.10.002.
Deetayart S, Thangturn W. Therapeutic efficacy of dexmedetomidine on hemodynamic response to skull pin holder placement: a randomized, double-blind controlled study. Thai J Anesthesiol. 2023;49:389–96.
Esmaeeli S, Valencia J, Buhl LK, Bastos AB, Goudarzi S, Eikermann M, et al. Anesthetic management of unruptured intracranial aneurysms: a qualitative systematic review. Neurosurg Rev. 2021;44(5):2477–92. Doi: https://doi.org/10.1007/s10143-020-01441-w.
Okazaki T, Kuroda Y. Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome. J Intensive Care. 2018;6(28):1-8. Doi: https://doi.org/10.1186/s40560-018- 0297-5.
